doxorubicin hydrochloride and Carcinoma, Pancreatic Ductal

doxorubicin hydrochloride has been researched along with Carcinoma, Pancreatic Ductal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bai, C; Chen, J; Chen, Y; Chong, C; Ding, Y; Gao, Y; Geng, Y; Li, J; Wang, M; Wu, L; Yu, J; Zhang, Q1
Che, Q; Li, D; Li, J; Liu, X; Shah, M; Sun, C; Sun, N; Zhang, G; Zhang, X; Zhu, T1

Reviews

1 review(s) available for doxorubicin hydrochloride and Carcinoma, Pancreatic Ductal

ArticleYear
Cytotoxic Nitrobenzoyl Sesquiterpenoids from an Antarctica Sponge-Derived
    Journal of natural products, 2022, 04-22, Volume: 85, Issue:4

    Topics: Antarctic Regions; Antineoplastic Agents; Apoptosis; Aspergillus; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Sesquiterpenes

2022

Other Studies

1 other study(ies) available for doxorubicin hydrochloride and Carcinoma, Pancreatic Ductal

ArticleYear
Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
    European journal of medicinal chemistry, 2018, May-10, Volume: 151

    Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Combinatorial Chemistry Techniques; Humans; Lipopeptides; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptides, Cyclic; Structure-Activity Relationship; Tumor Hypoxia

2018